{"name":"BioElectronics Corp","slug":"bioelectronics","ticker":"BIEL","exchange":"OTC","domain":"bielcorp.com","description":"BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions. It sells its products to wholesale distributors, hospitals and clinics, and consumers. The company was incorporated in 2000 and is headquartered in Frederick, Maryland.","hq":"Hackensack, NJ","founded":0,"employees":"","ceo":"Richard Staelin","sector":"Medical Devices — Electroceuticals","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$7M","metrics":{"revenue":3000000,"revenueGrowth":-65.1,"grossMargin":49.4,"rdSpend":0,"netIncome":-289821,"cash":925,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"BioElectronics Corp Reports Q4 2023 Earnings","summary":"The company reported revenue of $X.X million and a net loss of $X.X million for the quarter.","drugName":"","sentiment":"neutral"},{"date":"2023-06-01","type":"deal","headline":"BioElectronics Corp Partners with Medical Device Distributor","summary":"The company announced a partnership with a leading medical device distributor to expand its distribution network.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxNM05mOFI3RjYwMWg1WkN1cXBpZXhqSXJRNzU5TkJRMWEzTG96cjBYLXQxNFJrY1pTdHJqWlVpdWFhN2NhSHIxcVAzREhnTzE3d2J1VnF6TktvZktMaTdmVGhkcjlGaGo5VEJ5dncwcDhtYVNRNkgtay1yUVZnSHdoZGVvdDBZSmtMcjJyZF94dWpYWG84OGtZWkNJVWNkalNrcFFuM0V4NWVmQlBmU1p4V3VUc1F3MDg3TGxmMVZSVWlOaUdlMTdnLUFKQ21taU1JRWx5cWtpVWwwa0hhT3NJbg?oc=5","date":"2026-03-24","type":"deal","source":"PR Newswire","summary":"Electrome Launches PAINKILLER™ Bioelectric Pain Management Platform in Partnership with BIEL - PR Newswire","headline":"Electrome Launches PAINKILLER™ Bioelectric Pain Management Platform in Partnership with BIEL","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOLWZSTm1kMGxxOGI2RXg5QWtPQlhuZmwzX2RIMUJBQUgwWWc3Y2ppSDlnTlowRlRnRW8zRWEwWF9aY0RMZGhqY0lIU1QzTm5xajhucGViU0gzY0QtZHN0aXYxN3NMaXdsdEFESDVzdlowcjFiSHVnbTN1T2pQdXZpZWg4TTZSQmdjT2pQYUx3RFNlZDVWbk12aHEyeGlwTnZVSHc?oc=5","date":"2024-10-16","type":"pipeline","source":"Yahoo Finance","summary":"BioElectronics Corporation's Chairman Updates Investors - Yahoo Finance","headline":"BioElectronics Corporation's Chairman Updates Investors","sentiment":"neutral"},{"date":"2011-02-16","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2011-01-13","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"date":"2010-11-16","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2010-08-16","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2010-05-12","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2010-03-31","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC","headline":"Annual Report (10-K) Filed","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Zimmer Biomet","Stryker","Smith & Nephew"],"therapeuticFocus":["Pain Management"],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":null,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":null,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":0,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":0,"previousClose":0,"fiftyTwoWeekHigh":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekRange":"1.0E-4 - 0.0014","fiftyDayAverage":0,"twoHundredDayAverage":0,"beta":2.06,"enterpriseValue":20655320,"forwardPE":0,"priceToBook":-0.3,"priceToSales":4.6,"enterpriseToRevenue":12.83,"enterpriseToEbitda":0,"pegRatio":0,"ebitda":0,"ebitdaMargin":0,"freeCashflow":-554294,"operatingCashflow":-320299,"totalDebt":13342597,"debtToEquity":0,"currentRatio":0.01,"returnOnAssets":-33.7,"returnOnEquity":0,"analystRating":"","recommendationKey":"none","numberOfAnalysts":0,"targetMeanPrice":0,"targetHighPrice":0,"targetLowPrice":0,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":0,"institutionHeldPercent":0,"sharesOutstanding":24705066971,"floatShares":0,"sharesShort":0,"shortRatio":0,"shortPercentOfFloat":0,"epsTrailing":0,"epsForward":0,"revenuePerShare":0,"bookValue":0,"officers":[{"age":83,"name":"Mr. Andrew J. Whelan","title":"Founder"},{"age":null,"name":"Ms. Kelly A. Whelan","title":"CEO, President, Treasurer & Executive Director"},{"age":51,"name":"Mr. Keith E. Nalepka","title":"VP of Sales & Marketing and Executive Director"},{"age":null,"name":"Mr. John R. Martinez","title":"Secretary"}],"industry":"Medical Devices","irWebsite":"","website":"https://www.bielcorp.com","phone":"301 874 4890"}}